A Special Message from New UMDF President & CEO Kristen Clifford
To the mitochondrial disease community, As I wrap up my first full week as United Mitochondrial Disease Foundation (UMDF) President and...
Read moreLatest News -Press Room
United Mitochondrial Disease Foundation Names Kristen Clifford New President & CEO
The United Mitochondrial Disease Foundation (UMDF) Board of Trustees has named Kristen Clifford the organization’s next President and Chief...
Read moreJanuary 2025 Newsletter: Mito Med 2025 News, Advocacy Update, CPEO & MELAS Webcasts, and More
Sign-up to receive the UMDF newsletter via email at Newsletter Signup. Mitochondrial Medicine 2025Call For Abstracts Now OpenUMDF's Call...
Read moreDecember 2024 Newsletter: Mito Fund Investment, Mito Med 2025 News, Clinical Trial Updates, and More
Sign-up to receive the UMDF newsletter via email at Newsletter Signup. The Mito Fund Announces Investment in Khondrion UMDF’s venture...
Read moreThe Mito Fund Announces Investment in Khondrion to Support Development of One of the Most Advanced Drug Candidates for Primary Mitochondrial Disease
The United Mitochondrial Disease Foundation’s (UMDF) venture philanthropy arm, The Mito Fund, has invested in Khondrion, a Netherlands-based...
Read moreUMDF November Advocacy Update: What Does a Second Trump Administration Mean for the Mito Community?
With the recent election results, we’ve been getting some inquiries about the impact of a second Trump Administration on mitochondrial disease...
Read moreUMDF Cosigns Letter to Congress Encouraging End-of-Year Rare Disease Legislative Priorities
UMDF Cosigns Letter to Congress Encouraging End-of-Year Action on Accelerating Kids’ Access to Care Act, Rare Pediatric Disease Priority Review...
Read moreNovember 2024 Newsletter: FDA News, Rare Revolution Magazine Feature, Therapeutic Pipeline Updates, and more
Sign-up to receive the UMDF newsletter via email at Newsletter Signup. In early October, an FDA Advisory Committee voted 10-6 supporting...
Read moreAdvocacy Update – Oct 2024: FDA AdComm Brings Good News, Plus DC End of Year Business
FDA Advisory Committee Deems Potential Barth Syndrome Drug “Effective” Earlier this month, an FDA Advisory Committee voted 10-6...
Read more